In vitro studies have revealed very minimal probable for semaglutide to inhibit or induce CYP enzymes, and also to inhibit drug transporters. to lessen the chance of kidney ailment worsening, kidney failure (stop-stage kidney disorder), and death because of heart problems in Grownups with form two diabetes and Serious kidney disease to reduce